Actemra drug

If you have suffered serious side effects from Actemra, you may be entitled to compensation for your medical bills, lost income, pain and suffering, among other losses. We are currently working with some of the most experienced lawyers in the country, who are investigating to see if this is a dangerous drug. There is no fee until you obtain a settlement or award. For a free (no obligation) case evaluation fill out a contact form online or call us toll free.

What Is Actemra?

ActemraActemra (tocilizumab) is a prescription drug used to treat patients with severe rheumatoid arthritis and Giant Cell arteritis. It was developed by drug maker, Genentech/Roche, and generated about $1.7 billion in sales last year alone. The FDA approved Actemra in 2010 for rheumatoid arthritis treatment and again in 2017 for Giant Cell arteritis treatment. Since then, the FDA has received around 13,500 adverse event reports associated with Actemra, 1,100 of which included patients who died after using the drug.

What Is The Issue?

rheumatoid arthritisRecently, a study of those FDA adverse event reports was conducted by STAT, and they allege to have found an increase in medically adverse side effects in patients who use Actemra or other similar drugs to treat rheumatoid arthritis. The key issue with Actemra specifically, is that it is alleged that it may not contain an adequate enough warning of the side effects, like the other rheumatoid arthritis drugs in its class do. Competing drugs, such as Humira, Remicade, and Embrel, all warn of the risks of heart attack, stroke and lung disease, while some allege that Actemra does not. In fact, the study alleges that there may be evidence that associated Actemra with an even higher risk of these side effects than its competitors.

What Side Effects Are Alleged To Be Linked To Actemra?

    man having heart attack from Actemra

  • Pancreatitis
  • Heart Failure
  • Heart Attack
  • Stroke
  • Interstitial Lung Disease
  • Death

Will The FDA Take Action?

FDA testing Actemra

From 2010 to 2016, the FDA has received many complaints regarding Actemra. Of those complaints, it is alleged that over 1,100 of them involved deceased patients, who were actively taking Actemra. Many of those deaths were caused by heart and lung disorders, and strokes. While other drugs in this class contain warnings about these side effects, it is alleged by some that Actemra does not. It is also alleged by some that the FDA declined to comment about Actemra specifically, but issued a statement saying they are committed to warning the public in a timely manner when they identify safety issues. Since heart attacks, lung disease, and strokes can be caused by any number of things, the FDA cannot positively say that negative side effects from Actemra were the sole cause of death in these patients. However, the fact that all competing drugs have warning labels tailored specifically towards these medical issues, raises questions by some in terms of Actemra.

Why Contact d’Oliveira & Associates?

Actemra LawyerIf you or a loved one has suffered serious complications that you believe may be linked to taking Actemra, you may be entitled to compensation if more evidence comes forward indicating that the drug is dangerous. Please contact us toll free at 1-800-992-6878 or fill out a contact form online, for a free (no obligation) case evaluation.